2026 Minnesota Statutes

151.741 INSULIN MANUFACTURER REGISTRATION FEE.

Subdivision 1.Definitions.

(a) For purposes of this section, the following terms have the meanings given.

(b) "Board" means the Minnesota Board of Pharmacy under section 151.02.

(c) "Manufacturer" means a manufacturer licensed under section 151.252 and engaged in the manufacturing of prescription insulin.

Subd. 2.

MS 2024 [Repealed, 2026 c 127 art 4 s 25]

Subd. 3.

MS 2024 [Repealed, 2026 c 127 art 4 s 25]

Subd. 4.Insulin safety net program account.

(a) The insulin safety net program account is established in the special revenue fund in the state treasury. Money in the account is appropriated each fiscal year to:

(1) the MNsure board in an amount sufficient to carry out assigned duties under section 151.74, subdivision 7; and

(2) the Board of Pharmacy in an amount sufficient to cover costs incurred by the board in administering the insulin safety net program under section 151.74.

(b) The commissioner of management and budget shall annually transfer from the health care access fund to the insulin safety net program account an amount sufficient to implement paragraph (a).

Subd. 5.Insulin repayment account; annual transfer from health care access fund.

(a) The insulin repayment account is established in the special revenue fund in the state treasury. Money in the account is appropriated each fiscal year to the commissioner of administration to reimburse manufacturers for insulin dispensed under the insulin safety net program in section 151.74, in accordance with section 151.74, subdivisions 3, paragraph (h), and 6, paragraph (h), and to cover costs incurred by the commissioner in providing these reimbursement payments.

(b) Each June 30, the commissioner of administration shall certify to the commissioner of management and budget the total amount expended in the prior fiscal year for:

(1) reimbursement to manufacturers for insulin dispensed under the insulin safety net program in section 151.74, in accordance with section 151.74, subdivisions 3, paragraph (h), and 6, paragraph (h); and

(2) costs incurred by the commissioner of administration in providing the reimbursement payments described in clause (1).

(c) Each July 1, the commissioner of management and budget shall transfer from the health care access fund to the insulin repayment account an amount equal to the amount to which the commissioner of administration certified pursuant to paragraph (b).

Subd. 6.

MS 2024 [Repealed, 2026 c 127 art 4 s 25]

History:

2024 c 127 art 56 s 6; 2025 c 39 art 2 s 53; 2026 c 127 art 4 s 17,18